7
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1826L |
Dynorphin B (1-13) acetate(83335-41-5 free base)
|
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
Dynorphin B (1-13) acetate(83335-41-5 free base) 作为 opioid κ 受体的激动剂。 | |||
TP1826 |
Dynorphin B (1-13)
|
||
Dynorphin B (1-13) acts as an agonist on opioid κ-receptor. | |||
TP1372 |
Dynorphin B (1-13) (TFA)(83335-41-5,free)
Dynorphin B (1-13) (TFA) |
||
Dynorphin B (1-13), a 13 amino acid, is an extraordinarily potent opioid peptide. | |||
T82518 |
Dynorphin B 29 (pig)
Leumorphin (pig) |
||
Dynorphin B 29 (Leumorphin) (pig) 是一种可与大脑及孤立组织系统中的多种受体交互作用的肽,并可被用于研究免疫反应。 | |||
T80463 |
Dynorphin B (1-9)
|
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
Dynorphin B (1-9)为Dynorphin B的N-端裂解产物,属于神经肽类。其形成受到半胱氨酸肽酶非选择性抑制剂N-ethylmaleimide的阻断。 | |||
T75918 |
Dynorphin B (1-13) (TFA)
|
||
Dynorphin B (1-13) TFA 是一种阿片样 κ 受体 (κ-opioid receptor) 激动剂。 | |||
TP2243 |
Dynorphin (2-17), amide, porcine
|
Others | Others |
Dynorphins are a class of opioid peptides that arise from the precursor protein prodynorphin. When prodynorphin is cleaved during processing by proprotein convertase 2 (PC2), multiple active peptides are released: dynorphin A, dynorphin B, and α/β-neo-end |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00737 |
PDYN Protein, Human, Recombinant (His)
PDYN,ADCA,Big Dyn,Dynorphin B,PEN... |
Human | HEK293 Cells |
Proenkephalin-B(PDYN), belongs to the opioid neuropeptide precursor family. The N-terminal domain contains 6 conserved cysteines thought to be involved in disulfide bonding and/or processing. Leu-enkephalins, which is a type of Proenkephalin-B, compete with and mimic the effects of opiate drugs. They play a role in a number of physiologic functions, including pain perception and responses to stress. Dynorphin peptides differentially regulate the kappa opioid receptor. Dynorphin A has a typical o... | |||
TMPK-01413 |
H-2K (b) &B2M&OVA (SIINFEKL) Monomer Protein, Mouse, MHC (His & Avi)
H-2K,OVA,MHC,H2-K1 |
Mouse | HEK293 Cells |
Ovalbumin (OVA) has been historically a popular source of such antigens, since OVA can induce both humoral and cellular immune responses based on well-characterised peptide epitopes. The OVA257-264 octapeptide was one of the frst OVA epitopes to be characterised, it has an amino acid sequence SIINFEKL, which is recognised by cytotoxic T lymphocytes. SIINFEKL forms fbrillar assemblies similar to other peptide hydrogels. Te immunoactive properties of this peptide can therefore be related to its se... | |||
TMPK-01412 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi)
SARS-CoV-2 epitope,MHC |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. | |||
TMPK-01416 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,SARS-CoV-2 epitope |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. |